Skip to main content

Table 1 Clinical and genetic characteristics of colon cancer patients and tumors

From: Prognostic relevance of an epigenetic biomarker panel in sentinel lymph nodes from colon cancer patients

  Number of patients (n = 201) Percentage (%)
Stage
 I 38 19
 II 101 50
 III 62 31
N stage
 0 139 69
 1 47 23
 2 15 7
Grade
 Low 50 25
 Moderate 141 70
 High 10 5
Localization
 Proximal 129 64
 Distal 72 36
Gender
 Female 112 56
 Male 89 44
Age
 < 70 60 30
 ≥ 70 141 70
  Number of cancers (n = 197) Percentage (%)
MSI status
 MSI 61 31
 MSS 136 69
BRAF status
 Mutation 52 27
 Wild type 144 73
  1. The MSS group includes both MSS and MSI-low samples. BRAF status is evaluated for the V600E hotspot. For one cancer, BRAF status could not be determined
  2. MSI microsattelite instability, MSS microsattelite stable